#targeted therapy — Monday, March 23, 2026 (1 items)
| 0 | ℹ |
Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancer.
(elifesciences.org)
|
eLife 2026-03-23 | #amr #cancer #immunotherapy #signal transduction #targeted therapy |